title: Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
authors.forename: Vera
authors.initials: V
authors.lastname: Cappelletti
authors.forename: Silvia
authors.initials: S
authors.lastname: Veneroni
authors.forename: Danila
authors.initials: D
authors.lastname: Coradini
authors.forename: Saro
authors.initials: S
authors.lastname: Oriana
authors.forename: Gorana
authors.initials: G
authors.lastname: Tomasic
authors.forename: Mamoun
authors.initials: M
authors.lastname: Younes
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Daidone
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics* / Q000378:metabolism; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D007585:Jews / Q000706:statistics & numerical data; D009154:Mutation; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D011960:Receptors, Estrogen; D013629:Tamoxifen